Determination of diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone in plasma by solid-phase extraction and high-performance liquid chromatography
- 31 December 1988
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 432, 352-357
- https://doi.org/10.1016/s0378-4347(00)80665-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatographyInvestigational New Drugs, 1985
- Preliminary communication — Treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ; NSC-182986)American Journal of Clinical Oncology, 1983
- Diaziquone (AZQ)Investigational New Drugs, 1983
- Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1Journal of Medicinal Chemistry, 1976